Global and China DNA Repair Drugs Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global DNA Repair Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.6% in the forecast period of 2020 to 2025 and will expected to reach USD 1009 million by 2025, from USD 527.9 million in 2019.
The DNA Repair Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
DNA Repair Drugs market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, DNA Repair Drugs market has been segmented into PARP Inhibitors, Other, etc.
Breakdown by Application, DNA Repair Drugs has been segmented into Oncological, Stroke, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global DNA Repair Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level DNA Repair Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global DNA Repair Drugs market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and DNA Repair Drugs Market Share Analysis
DNA Repair Drugs competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, DNA Repair Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the DNA Repair Drugs sales, revenue and market share for each player covered in this report.
The major players covered in DNA Repair Drugs are: 4SC AG, German Breast Group, British Columbia Cancer Agency, ARCAGY/ GINECO GROUP, Georgetown University, Bristol Myers Squibb, Jiangsu Hengrui Medicine, Genentech, Cambridge University Hospitals NHS Foundation Trust, GlaxoSmithKline, National Health Service, Johnson & Johnson, National Institutes of Health, KuDOS Pharmaceuticals, Jonsson Comprehensive Cancer Center, Tesaro, Karyopharm Therapeutics, etc. Among other players domestic and global, DNA Repair Drugs market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global DNA Repair Drugs market are listed below:
4SC AG
German Breast Group
British Columbia Cancer Agency
ARCAGY/ GINECO GROUP
Georgetown University
Bristol Myers Squibb
Jiangsu Hengrui Medicine
Genentech
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline
National Health Service
Johnson & Johnson
National Institutes of Health
KuDOS Pharmaceuticals
Jonsson Comprehensive Cancer Center
Tesaro
Karyopharm Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
PARP Inhibitors
Other
Market segment by Application, can be divided into
Oncological
Stroke
Table of Contents
1 Market Overview
1.1 DNA Repair Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global DNA Repair Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 PARP Inhibitors
1.2.3 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global DNA Repair Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncological
1.3.3 Stroke
1.4 Global DNA Repair Drugs Market Size and Forecast (2015-2025)
1.4.1 Global DNA Repair Drugs Revenue and Forecast (2015-2025)
1.4.2 Global DNA Repair Drugs Sales and Forecast (2015-2025)
1.5 Global DNA Repair Drugs Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 4SC AG
2.1.1 4SC AG Details
2.1.2 4SC AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 4SC AG SWOT Analysis
2.1.4 4SC AG Product and Services
2.1.5 4SC AG DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 German Breast Group
2.2.1 German Breast Group Details
2.2.2 German Breast Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 German Breast Group SWOT Analysis
2.2.4 German Breast Group Product and Services
2.2.5 German Breast Group DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 British Columbia Cancer Agency
2.3.1 British Columbia Cancer Agency Details
2.3.2 British Columbia Cancer Agency Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 British Columbia Cancer Agency SWOT Analysis
2.3.4 British Columbia Cancer Agency Product and Services
2.3.5 British Columbia Cancer Agency DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 ARCAGY/ GINECO GROUP
2.4.1 ARCAGY/ GINECO GROUP Details
2.4.2 ARCAGY/ GINECO GROUP Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 ARCAGY/ GINECO GROUP SWOT Analysis
2.4.4 ARCAGY/ GINECO GROUP Product and Services
2.4.5 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Georgetown University
2.5.1 Georgetown University Details
2.5.2 Georgetown University Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Georgetown University SWOT Analysis
2.5.4 Georgetown University Product and Services
2.5.5 Georgetown University DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol Myers Squibb SWOT Analysis
2.6.4 Bristol Myers Squibb Product and Services
2.6.5 Bristol Myers Squibb DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Jiangsu Hengrui Medicine
2.7.1 Jiangsu Hengrui Medicine Details
2.7.2 Jiangsu Hengrui Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Jiangsu Hengrui Medicine SWOT Analysis
2.7.4 Jiangsu Hengrui Medicine Product and Services
2.7.5 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genentech SWOT Analysis
2.8.4 Genentech Product and Services
2.8.5 Genentech DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cambridge University Hospitals NHS Foundation Trust
2.9.1 Cambridge University Hospitals NHS Foundation Trust Details
2.9.2 Cambridge University Hospitals NHS Foundation Trust Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cambridge University Hospitals NHS Foundation Trust SWOT Analysis
2.9.4 Cambridge University Hospitals NHS Foundation Trust Product and Services
2.9.5 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline SWOT Analysis
2.10.4 GlaxoSmithKline Product and Services
2.10.5 GlaxoSmithKline DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 National Health Service
2.11.1 National Health Service Details
2.11.2 National Health Service Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 National Health Service SWOT Analysis
2.11.4 National Health Service Product and Services
2.11.5 National Health Service DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Johnson & Johnson
2.12.1 Johnson & Johnson Details
2.12.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Johnson & Johnson SWOT Analysis
2.12.4 Johnson & Johnson Product and Services
2.12.5 Johnson & Johnson DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 National Institutes of Health
2.13.1 National Institutes of Health Details
2.13.2 National Institutes of Health Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 National Institutes of Health SWOT Analysis
2.13.4 National Institutes of Health Product and Services
2.13.5 National Institutes of Health DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 KuDOS Pharmaceuticals
2.14.1 KuDOS Pharmaceuticals Details
2.14.2 KuDOS Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 KuDOS Pharmaceuticals SWOT Analysis
2.14.4 KuDOS Pharmaceuticals Product and Services
2.14.5 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Jonsson Comprehensive Cancer Center
2.15.1 Jonsson Comprehensive Cancer Center Details
2.15.2 Jonsson Comprehensive Cancer Center Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Jonsson Comprehensive Cancer Center SWOT Analysis
2.15.4 Jonsson Comprehensive Cancer Center Product and Services
2.15.5 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Tesaro
2.16.1 Tesaro Details
2.16.2 Tesaro Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Tesaro SWOT Analysis
2.16.4 Tesaro Product and Services
2.16.5 Tesaro DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Karyopharm Therapeutics
2.17.1 Karyopharm Therapeutics Details
2.17.2 Karyopharm Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Karyopharm Therapeutics SWOT Analysis
2.17.4 Karyopharm Therapeutics Product and Services
2.17.5 Karyopharm Therapeutics DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global DNA Repair Drugs Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global DNA Repair Drugs Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global DNA Repair Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players DNA Repair Drugs Sales in China (2018-2019)
3.2.2 China DNA Repair Drugs Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 DNA Repair Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 DNA Repair Drugs Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global DNA Repair Drugs Market Size by Geography (2015-2020)
4.1.1 Global DNA Repair Drugs Sales by Geography (2015-2020)
4.1.2 Global DNA Repair Drugs Revenue by Regions (2015-2020)
4.2 Global DNA Repair Drugs Market Size and Forecast by Regions (2020-2025)
4.2.1 Global DNA Repair Drugs Sales and Forecast by Regions (2020-2025)
4.2.2 Global DNA Repair Drugs Revenue and Forecast by Regions (2020-2025)
4.3 North America DNA Repair Drugs Market Size and Forecast (2015-2025)
4.4 Europe DNA Repair Drugs Market Size and Forecast (2015-2025)
4.5 Asia-Pacific DNA Repair Drugs Market Size and Forecast (2015-2025)
4.6 South America DNA Repair Drugs Market Size and Forecast (2015-2025)
4.7 Middle East and Africa DNA Repair Drugs Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America DNA Repair Drugs Market Size by Country (2015-2020)
5.1.1 North America DNA Repair Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America DNA Repair Drugs Revenue and Market Share by Country (2015-2020)
5.2 North America DNA Repair Drugs Market Size and Forecast by Country (2020-2025)
5.2.1 North America DNA Repair Drugs Sales and Forecast by Country (2020-2025)
5.2.2 North America DNA Repair Drugs Revenue and Forecast by Country (2020-2025)
5.3 United States DNA Repair Drugs Market Size and Forecast (2015-2025)
5.4 Canada DNA Repair Drugs Market Size and Forecast (2015-2025)
5.5 Mexico DNA Repair Drugs Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe DNA Repair Drugs Market Size by Country (2015-2020)
6.1.1 Europe DNA Repair Drugs Sales by Country (2015-2020)
6.1.2 Europe DNA Repair Drugs Revenue by Country (2015-2020)
6.2 Europe DNA Repair Drugs Market Size and Forecast by Country (2020-2025)
6.2.1 Europe DNA Repair Drugs Sales and Forecast by Country (2020-2025)
6.2.2 Europe DNA Repair Drugs Revenue and Forecast by Country (2020-2025)
6.3 Germany DNA Repair Drugs Market Size and Forecast (2015-2025)
6.4 United Kingdom DNA Repair Drugs Market Size and Forecast (2015-2025)
6.5 France DNA Repair Drugs Market Size and Forecast (2015-2025)
6.6 Russia DNA Repair Drugs Market Size and Forecast (2015-2025)
6.7 Italy DNA Repair Drugs Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific DNA Repair Drugs Market Size by Region (2015-2020)
7.1.1 Asia-Pacific DNA Repair Drugs Sales by Region (2015-2020)
7.1.2 Asia-Pacific DNA Repair Drugs Revenue by Region (2015-2020)
7.2 Asia-Pacific DNA Repair Drugs Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific DNA Repair Drugs Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific DNA Repair Drugs Revenue and Forecast by Region (2020-2025)
7.3 China DNA Repair Drugs Market Size and Forecast (2015-2025)
7.4 Japan DNA Repair Drugs Market Size and Forecast (2015-2025)
7.5 Korea DNA Repair Drugs Market Size and Forecast (2015-2025)
7.6 India DNA Repair Drugs Market Size and Forecast (2015-2025)
7.7 Southeast Asia DNA Repair Drugs Market Size and Forecast (2015-2025)
7.8 Australia DNA Repair Drugs Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America DNA Repair Drugs Market Size by Country (2015-2020)
8.1.1 South America DNA Repair Drugs Sales by Country (2015-2020)
8.1.2 South America DNA Repair Drugs Revenue by Country (2015-2020)
8.2 South America DNA Repair Drugs Market Size and Forecast by Country (2020-2025)
8.2.1 South America DNA Repair Drugs Sales and Forecast by Country (2020-2025)
8.2.2 South America DNA Repair Drugs Revenue and Forecast by Country (2020-2025)
8.3 Brazil DNA Repair Drugs Market Size and Forecast (2015-2025)
8.4 Argentina DNA Repair Drugs Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa DNA Repair Drugs Market Size by Country (2015-2020)
9.1.1 Middle East & Africa DNA Repair Drugs Sales by Country (2015-2020)
9.1.2 Middle East & Africa DNA Repair Drugs Revenue by Country (2015-2020)
9.2 Middle East & Africa DNA Repair Drugs Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa DNA Repair Drugs Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa DNA Repair Drugs Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia DNA Repair Drugs Market Size and Forecast (2015-2025)
9.4 Turkey DNA Repair Drugs Market Size and Forecast (2015-2025)
9.5 Egypt DNA Repair Drugs Market Size and Forecast (2015-2025)
9.6 South Africa DNA Repair Drugs Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global DNA Repair Drugs Market Size by Type (2015-2020)
10.1.1 Global DNA Repair Drugs Sales by Type (2015-2020)
10.1.2 Global DNA Repair Drugs Revenue by Type (2015-2020)
10.1.3 Global DNA Repair Drugs Price by Type (2015-2020)
10.2 Global DNA Repair Drugs Market Size and Forecast by Type (2020-2025)
10.2.1 Global DNA Repair Drugs Sales and Forecast by Type (2020-2025)
10.2.2 Global DNA Repair Drugs Revenue and Forecast by Type (2020-2025)
10.2.3 Global DNA Repair Drugs Price and Forecast by Type (2020-2025)
10.3 China DNA Repair Drugs Market Size and Forecast by Type (2015-2025)
10.3.1 China DNA Repair Drugs Market Size by Type (2015-2020)
10.3.2 China DNA Repair Drugs Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global DNA Repair Drugs Market Size by Application (2015-2020)
11.1.1 Global DNA Repair Drugs Sales by Application (2015-2020)
11.1.2 Global DNA Repair Drugs Revenue by Application (2015-2020)
11.1.3 Global DNA Repair Drugs Price by Application (2015-2020)
11.2 Global DNA Repair Drugs Market Size and Forecast by Application (2020-2025)
11.2.1 Global DNA Repair Drugs Sales and Forecast by Application (2020-2025)
11.2.2 Global DNA Repair Drugs Revenue and Forecast by Application (2020-2025)
11.2.3 Global DNA Repair Drugs Price and Forecast by Application (2020-2025)
11.3 China DNA Repair Drugs Market Size and Forecast by Application (2015-2025)
11.3.1 China DNA Repair Drugs Market Size by Application (2015-2020)
11.3.2 China DNA Repair Drugs Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global DNA Repair Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of DNA Repair Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global DNA Repair Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global DNA Repair Drugs Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. 4SC AG Basic Information, Manufacturing Base and Competitors
Table 6. 4SC AG DNA Repair Drugs Major Business
Table 7. 4SC AG DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 8. 4SC AG SWOT Analysis
Table 9. 4SC AG DNA Repair Drugs Product and Services
Table 10. 4SC AG DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. German Breast Group Basic Information, Manufacturing Base and Competitors
Table 12. German Breast Group DNA Repair Drugs Major Business
Table 13. German Breast Group DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 14. German Breast Group SWOT Analysis
Table 15. German Breast Group DNA Repair Drugs Product and Services
Table 16. German Breast Group DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. British Columbia Cancer Agency Basic Information, Manufacturing Base and Competitors
Table 18. British Columbia Cancer Agency DNA Repair Drugs Major Business
Table 19. British Columbia Cancer Agency DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 20. British Columbia Cancer Agency SWOT Analysis
Table 21. British Columbia Cancer Agency DNA Repair Drugs Product and Services
Table 22. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. ARCAGY/ GINECO GROUP Basic Information, Manufacturing Base and Competitors
Table 24. ARCAGY/ GINECO GROUP DNA Repair Drugs Major Business
Table 25. ARCAGY/ GINECO GROUP DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 26. ARCAGY/ GINECO GROUP SWOT Analysis
Table 27. ARCAGY/ GINECO GROUP DNA Repair Drugs Product and Services
Table 28. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Georgetown University Basic Information, Manufacturing Base and Competitors
Table 30. Georgetown University DNA Repair Drugs Major Business
Table 31. Georgetown University DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 32. Georgetown University SWOT Analysis
Table 33. Georgetown University DNA Repair Drugs Product and Services
Table 34. Georgetown University DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol Myers Squibb DNA Repair Drugs Major Business
Table 37. Bristol Myers Squibb DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 38. Bristol Myers Squibb SWOT Analysis
Table 39. Bristol Myers Squibb DNA Repair Drugs Product and Services
Table 40. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 42. Jiangsu Hengrui Medicine DNA Repair Drugs Major Business
Table 43. Jiangsu Hengrui Medicine DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 44. Jiangsu Hengrui Medicine SWOT Analysis
Table 45. Jiangsu Hengrui Medicine DNA Repair Drugs Product and Services
Table 46. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Genentech Basic Information, Manufacturing Base and Competitors
Table 48. Genentech DNA Repair Drugs Major Business
Table 49. Genentech DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 50. Genentech SWOT Analysis
Table 51. Genentech DNA Repair Drugs Product and Services
Table 52. Genentech DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Cambridge University Hospitals NHS Foundation Trust Basic Information, Manufacturing Base and Competitors
Table 54. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Major Business
Table 55. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 56. Cambridge University Hospitals NHS Foundation Trust SWOT Analysis
Table 57. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product and Services
Table 58. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 60. GlaxoSmithKline DNA Repair Drugs Major Business
Table 61. GlaxoSmithKline DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 62. GlaxoSmithKline SWOT Analysis
Table 63. GlaxoSmithKline DNA Repair Drugs Product and Services
Table 64. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. National Health Service Basic Information, Manufacturing Base and Competitors
Table 66. National Health Service DNA Repair Drugs Major Business
Table 67. National Health Service DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 68. National Health Service SWOT Analysis
Table 69. National Health Service DNA Repair Drugs Product and Services
Table 70. National Health Service DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 72. Johnson & Johnson DNA Repair Drugs Major Business
Table 73. Johnson & Johnson DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 74. Johnson & Johnson SWOT Analysis
Table 75. Johnson & Johnson DNA Repair Drugs Product and Services
Table 76. Johnson & Johnson DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. National Institutes of Health Basic Information, Manufacturing Base and Competitors
Table 78. National Institutes of Health DNA Repair Drugs Major Business
Table 79. National Institutes of Health DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 80. National Institutes of Health SWOT Analysis
Table 81. National Institutes of Health DNA Repair Drugs Product and Services
Table 82. National Institutes of Health DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. KuDOS Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. KuDOS Pharmaceuticals DNA Repair Drugs Major Business
Table 85. KuDOS Pharmaceuticals DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 86. KuDOS Pharmaceuticals SWOT Analysis
Table 87. KuDOS Pharmaceuticals DNA Repair Drugs Product and Services
Table 88. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. Jonsson Comprehensive Cancer Center Basic Information, Manufacturing Base and Competitors
Table 90. Jonsson Comprehensive Cancer Center DNA Repair Drugs Major Business
Table 91. Jonsson Comprehensive Cancer Center DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 92. Jonsson Comprehensive Cancer Center SWOT Analysis
Table 93. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product and Services
Table 94. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. Tesaro Basic Information, Manufacturing Base and Competitors
Table 96. Tesaro DNA Repair Drugs Major Business
Table 97. Tesaro DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 98. Tesaro SWOT Analysis
Table 99. Tesaro DNA Repair Drugs Product and Services
Table 100. Tesaro DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 101. Karyopharm Therapeutics Basic Information, Manufacturing Base and Competitors
Table 102. Karyopharm Therapeutics DNA Repair Drugs Major Business
Table 103. Karyopharm Therapeutics DNA Repair Drugs Total Revenue (USD Million) (2018-2019)
Table 104. Karyopharm Therapeutics SWOT Analysis
Table 105. Karyopharm Therapeutics DNA Repair Drugs Product and Services
Table 106. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 107. Global DNA Repair Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 108. Global DNA Repair Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 109. Key Players DNA Repair Drugs Sales in China (2018-2019) (K Units)
Table 110. Key Players DNA Repair Drugs Sales Market Share in China (2018-2019)
Table 111. Key Players Revenue of DNA Repair Drugs in China (2018-2019) (USD Million)
Table 112. Global DNA Repair Drugs Sales by Regions (2015-2020) (K Units)
Table 113. Global DNA Repair Drugs Sales Market Share by Regions (2015-2020)
Table 114. Global DNA Repair Drugs Revenue by Regions (2015-2020) (USD Million)
Table 115. Global DNA Repair Drugs Sales and Forecast by Regions (2020-2025) (K Units)
Table 116. Global DNA Repair Drugs Sales Market Share by Regions (2020-2025)
Table 117. Global DNA Repair Drugs Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 118. Global DNA Repair Drugs Revenue Market Share by Regions (2020-2025) (USD Million)
Table 119. North America DNA Repair Drugs Sales by Countries (2015-2020) (K Units)
Table 120. North America DNA Repair Drugs Sales Market Share by Countries (2015-2020)
Table 121. North America DNA Repair Drugs Revenue by Countries (2015-2020) (USD Million)
Table 122. North America DNA Repair Drugs Revenue Market Share by Countries (2015-2020)
Table 123. North America DNA Repair Drugs Sales by Country (2020-2025) (K Units)
Table 124. North America DNA Repair Drugs Sales Market Share by Country (2020-2025)
Table 125. North America DNA Repair Drugs Revenue by Country (2020-2025) (USD Million)
Table 126. North America DNA Repair Drugs Revenue Market Share by Country (2020-2025)
Table 127. Europe DNA Repair Drugs Sales by Countries (2015-2020) (K Units)
Table 128. Europe DNA Repair Drugs Sales Market Share by Countries (2015-2020)
Table 129. Europe DNA Repair Drugs Revenue by Countries (2015-2020) (USD Million)
Table 130. Europe DNA Repair Drugs Revenue Market Share by Countries (2015-2020)
Table 131. Europe DNA Repair Drugs Sales by Country (2020-2025) (K Units)
Table 132. Europe DNA Repair Drugs Sales Market Share by Country (2020-2025)
Table 133. Europe DNA Repair Drugs Revenue by Country (2020-2025) (USD Million)
Table 134. Europe DNA Repair Drugs Revenue Market Share by Country (2020-2025)
Table 135. Asia-Pacific DNA Repair Drugs Sales by Countries (2015-2020) (K Units)
Table 136. Asia-Pacific DNA Repair Drugs Sales Market Share by Countries (2015-2020)
Table 137. Asia-Pacific DNA Repair Drugs Revenue by Countries (2015-2020) (USD Million)
Table 138. Asia-Pacific DNA Repair Drugs Revenue Market Share by Countries (2015-2020)
Table 139. Asia-Pacific DNA Repair Drugs Sales by Country (2020-2025) (K Units)
Table 140. Asia-Pacific DNA Repair Drugs Sales Market Share by Country (2020-2025)
Table 141. Asia-Pacific DNA Repair Drugs Revenue by Country (2020-2025) (USD Million)
Table 142. Asia-Pacific DNA Repair Drugs Revenue Market Share by Country (2020-2025)
Table 143. South America DNA Repair Drugs Sales by Countries (2015-2020) (K Units)
Table 144. South America DNA Repair Drugs Sales Market Share by Countries (2015-2020)
Table 145. South America DNA Repair Drugs Revenue by Countries (2015-2020) (USD Million)
Table 146. South America DNA Repair Drugs Revenue Market Share by Countries (2015-2020)
Table 147. South America DNA Repair Drugs Sales by Country (2020-2025) (K Units)
Table 148. South America DNA Repair Drugs Sales Market Share by Country (2020-2025)
Table 149. South America DNA Repair Drugs Revenue by Country (2020-2025) (USD Million)
Table 150. South America DNA Repair Drugs Revenue Market Share by Country (2020-2025)
Table 151. Middle East & Africa DNA Repair Drugs Sales by Countries (2015-2020) (K Units)
Table 152. Middle East & Africa DNA Repair Drugs Sales Market Share by Countries (2015-2020)
Table 153. Middle East & Africa DNA Repair Drugs Revenue by Countries (2015-2020) (USD Million)
Table 154. Middle East & Africa DNA Repair Drugs Revenue Market Share by Countries (2015-2020)
Table 155. Middle East & Africa DNA Repair Drugs Sales by Country (2020-2025) (K Units)
Table 156. Middle East & Africa DNA Repair Drugs Sales Market Share by Country (2020-2025)
Table 157. Middle East & Africa DNA Repair Drugs Revenue by Country (2020-2025) (USD Million)
Table 158. Middle East & Africa DNA Repair Drugs Revenue Market Share by Country (2020-2025)
Table 159. China DNA Repair Drugs Sales by Type (2015-2020) (K Units)
Table 160. China DNA Repair Drugs Sales Market Share by Type (2015-2020)
Table 161. China DNA Repair Drugs Revenue by Type (2015-2020) (USD Million)
Table 162. China DNA Repair Drugs Revenue Market Share by Type (2015-2020)
Table 163. China DNA Repair Drugs Sales by Type (2020-2025) (K Units)
Table 164. China DNA Repair Drugs Sales Market Share by Type (2020-2025)
Table 165. China DNA Repair Drugs Revenue by Type (2020-2025) (USD Million)
Table 166. China DNA Repair Drugs Revenue Market Share by Type (2020-2025)
Table 167. Global DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 168. Global DNA Repair Drugs Sales Market Share by Application (2015-2020)
Table 169. Global DNA Repair Drugs Revenue by Application (2015-2020) (USD Million)
Table 170. Global DNA Repair Drugs Revenue Market Share by Application (2015-2020)
Table 171. Global DNA Repair Drugs Price by Application (2015-2020) (USD/Unit)
Table 172. Global DNA Repair Drugs Sales by Application (2020-2025) (K Units)
Table 173. Global DNA Repair Drugs Sales Market Share by Application (2020-2025)
Table 174. Global DNA Repair Drugs Revenue by Application (2020-2025) (USD Million)
Table 175. Global DNA Repair Drugs Revenue Market Share by Application (2020-2025)
Table 176. Global DNA Repair Drugs Price by Application (2020-2025) (USD/Unit)
Table 177. China DNA Repair Drugs Sales by Application (2015-2020) (K Units)
Table 178. China DNA Repair Drugs Sales Market Share by Application (2015-2020)
Table 179. China DNA Repair Drugs Revenue by Application (2015-2020) (USD Million)
Table 180. China DNA Repair Drugs Revenue Market Share by Application (2015-2020)
Table 181. China DNA Repair Drugs Sales by Application (2020-2025) (K Units)
Table 182. China DNA Repair Drugs Sales Market Share by Application (2020-2025)
Table 183. China DNA Repair Drugs Revenue by Application (2020-2025) (USD Million)
Table 184. China DNA Repair Drugs Revenue Market Share by Application (2020-2025)
Table 185. Direct Channel Pros & Cons
Table 186. Indirect Channel Pros & Cons
Table 187. Distributors/Traders/ Dealers List
Table 188. Customers of DNA Repair Drugs
Table 189. Market Opportunities in Next Few Years
Table 190. Market Risks Analysis
Table 191. Market Drivers
List of Figures
Figure 1. DNA Repair Drugs Picture
Figure 2. Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. PARP Inhibitors Picture
Figure 4. Other Picture
Figure 5. DNA Repair Drugs Sales Market Share by Application in 2019
Figure 6. Oncological Picture
Figure 7. Stroke Picture
Figure 8. Global DNA Repair Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. Global DNA Repair Drugs Sales Growth Rate (2015-2025) (K Units)
Figure 10. Global DNA Repair Drugs Sales Market Share by Manufacturer in 2019
Figure 11. Global DNA Repair Drugs Revenue Market Share by Manufacturer in 2019
Figure 12. Key Players DNA Repair Drugs Revenue Market Share in China in 2019
Figure 13. Global Top 5 DNA Repair Drugs Manufacturer Market Share in 2019
Figure 14. Top 3 DNA Repair Drugs Players Market Share in China in 2019
Figure 15. Global DNA Repair Drugs Revenue Market Share by Regions in 2019
Figure 16. North America DNA Repair Drugs Sales YoY Growth (2015-2025) (K Units)
Figure 17. North America DNA Repair Drugs Revenue YoY Growth (2015-2025) (USD Million)
Figure 18. Europe DNA Repair Drugs Sales YoY Growth (2015-2020) (K Units)
Figure 19. Europe DNA Repair Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 20. Asia-Pacific DNA Repair Drugs Sales YoY Growth (2015-2020) (K Units)
Figure 21. Asia-Pacific DNA Repair Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 22. South America DNA Repair Drugs Sales YoY Growth (2015-2020) (K Units)
Figure 23. South America DNA Repair Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Middle East & Africa DNA Repair Drugs Sales YoY Growth (2015-2020) (K Units)
Figure 25. Middle East & Africa DNA Repair Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. North America DNA Repair Drugs Sales Market Share by Country in 2019
Figure 27. North America DNA Repair Drugs Revenue Market Share by Country in 2019
Figure 28. United States DNA Repair Drugs Market Size and Growth Rate (2015-2025) (USD Million)
Figure 29. Canada DNA Repair Drugs Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Mexico DNA Repair Drugs Market Size and Growth Rate (2015-2020) (USD Million)
Figure 31. Europe DNA Repair Drugs Revenue Market Share by Country in 2019
Figure 32. Germany DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 33. United Kingdom DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. France DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. Russia DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Italy DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Asia-Pacific DNA Repair Drugs Sales Market Share by Region 2018
Figure 38. Asia-Pacific DNA Repair Drugs Revenue Market Share by Region 2018
Figure 39. China DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Japan DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Korea DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. India DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Southeast Asia DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Australia DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. South America DNA Repair Drugs Sales Market Share by Country in 2019
Figure 46. South America DNA Repair Drugs Revenue Market Share by Country in 2019
Figure 47. Brazil DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Argentina DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Saudi Arabia DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Turkey DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Egypt DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. South Africa DNA Repair Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Global Revenue Market Share of DNA Repair Drugs by Type in 2019
Figure 54. Global Revenue Market Share of DNA Repair Drugs by Application in 2019
Figure 55. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
4SC AG
German Breast Group
British Columbia Cancer Agency
ARCAGY/ GINECO GROUP
Georgetown University
Bristol Myers Squibb
Jiangsu Hengrui Medicine
Genentech
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline
National Health Service
Johnson & Johnson
National Institutes of Health
KuDOS Pharmaceuticals
Jonsson Comprehensive Cancer Center
Tesaro
Karyopharm Therapeutics
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets